Safety pacing in multi-site CRM devices

• US 8,260,417 B2
• Filed: 11/17/2009
• Issued: 09/04/2012
• Est. Priority Date: 12/26/2000
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Stahmann, Jeffrey E., Kramer, Andrew P., Calkins, Hugh
• Primary Examiner(s): Layno, Carl H
• Assistant Examiner(s): Stice, Paula J
• Application Number:
  US12/620,312
• Publication Number:
  US 20100063560A1
• Time in Patent Office: 1,022 Days
• Field of Search: 607 1- 25, 607/27
• US Class Current: 607/9
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/368 comprising more than one electrode co-operating with different heart regions A61N1/3622, A61N1/3627 take precedence
• CPC Class Codes: A61N 1/3684 for stimulating the heart at multiple sites of the ventricle or the atrium
• CPC Class Codes: A61N 1/36842 Multi-site stimulation in the same chamber
• CPC Class Codes: A61N 1/36843 Bi-ventricular stimulation

Abstract

Safety pacing in multi-site cardiac rhythm management (CRM) devices is provided. According to various method embodiments, a first cardiac signal from a first cardiac region and a second cardiac signal from a second cardiac region are sensed. The first cardiac region is paced to maintain at least a minimum cardiac rate, and the second cardiac region is paced to maintain at least the minimum cardiac rate when a pace in the first cardiac region is inhibited. Other aspects and embodiments are provided herein.

Claims

1. A method for using at least two electrodes implanted in or proximate to a heart chamber, wherein the at least two electrodes include a first electrode and a second electrode, the method comprising:

using the first electrode operationally positioned proximate to a first site of the heart chamber to pace the first site or to sense a cardiac activation at the first site, wherein the second electrode is not used with the first electrode to pace the first site, wherein using the first electrode to pace the first site includes delivering a programmed pacing therapy to pace the heart chamber at the first site using the first electrode; and

using the second electrode operationally positioned proximate to a second site of the heart chamber to provide pacing redundancy for the heart chamber or to provide sensing redundancy for the heart chamber,

wherein the programmed pacing therapy to pace the heart chamber using the first electrode does not pace the second site using the second electrode if the heart chamber is paced at the first site using the first electrode, using the second electrode to provide pacing redundancy for the heart chamber includes responding to a failure or an algorithm that inhibits a pace to the first site, and responding includes pacing the heart chamber by delivering a pace to the second site instead of the first site.

2. The method of claim 1, wherein:

using the first electrode includes pacing the first site of the heart chamber using the first electrode; and

using the second electrode includes sensing cardiac activation at the second site of the heart chamber using the second electrode and determining if cardiac activation at the second site occurs within an expected conduction delay window from a time when the first site is paced.

3. The method of claim 1, wherein:

using the first electrode includes sensing the cardiac activation at the first site of the heart chamber using the first electrode; and

using the second electrode includes sensing cardiac activation at the second site of the heart chamber using the second electrode and determining if the cardiac activation at the second site occurs within an expected conduction delay window from the cardiac activation at the first site.

4. A method for using multiple electrodes implanted in or proximate to a left ventricle, the method comprising:

using a first electrode operationally positioned proximate to a first site of the left ventricle to pace the first site or to sense a cardiac activation at the first site, wherein using the first electrode to pace the first site includes delivering a programmed pacing therapy to pace the left ventricle at the first site using the first electrode; and

using at least one alternative electrode to the first electrode to provide pacing redundancy or to provide sensing redundancy for the left ventricle, wherein the at least one alternative electrode is operationally positioned to an alternative site of the left ventricle and is not used with the first electrode to pace the first site or to sense the cardiac activation at the first site,

wherein the programmed pacing therapy to pace the left ventricle using the first electrode does not pace the second site using the at least one alternative electrode if the left ventricle is paced at the first site using the first electrode, using the at least one alternative electrode to provide pacing redundancy for the left ventricle includes responding to a failure or an algorithm that inhibits a pace to the first site, and responding includes pacing the heart chamber by delivering a pace to the alternative site using the at least one alternative electrode instead of the first electrode.

5. The method of claim 4, wherein:

using the first electrode includes pacing the first site of the left ventricle using the first electrode; and

using the at least one alternative electrode includes sensing cardiac activation at the alternative site of the left ventricle using the at least one alternative electrode and determining if cardiac activation at the alternative site occurs within an expected conduction delay window from a time when the first site is paced.

6. The method of claim 4, wherein:

using the first electrode includes sensing the cardiac activation at the first site of the left ventricle using the first electrode; and

using the at least one alternative electrode includes sensing cardiac activation at the alternate site of the left ventricle using the at least one alternative electrode and determining if the cardiac activation at the alternate site occurs within an expected conduction delay window from the cardiac activation at the first site.

7. A method for using multiple electrodes implanted in or proximate to a left ventricle, the method comprising:

using a first electrode operationally positioned proximate to a first site of the left ventricle to pace the first site or to sense a cardiac activation at the first site, wherein using the first electrode to pace the first site includes delivering a programmed pacing therapy to pace the left ventricle at the first site using the first electrode; and

using at least one additional electrode to the first electrode to provide pacing redundancy or to provide sensing redundancy for the left ventricle, wherein the at least one additional electrode is operationally positioned to an additional site of the left ventricle,

wherein the programmed pacing therapy to pace the left ventricle using the first electrode does not pace the additional site using the at least one additional electrode if the left ventricle is paced at the first site using the first electrode, using the at least one additional electrode to provide pacing redundancy for the left ventricle includes responding to a failure or an algorithm that inhibits a pace to the first site, and responding includes pacing the heart chamber by delivering a pace to the additional site using the at least one additional electrode.

8. The method of claim 7, wherein:

using the first electrode includes pacing the first site of the left ventricle using the first electrode; and

using the at least one additional electrode includes sensing cardiac activation at the other site of the left ventricle using the at least one additional electrode and determining if cardiac activation at the other site occurs within an expected conduction delay window from a time when the first site is paced.

9. The method of claim 7, wherein:

using the first electrode includes sensing the cardiac activation at the first site of the left ventricle using the first electrode; and

using the at least one additional electrode includes sensing cardiac activation at the other site of the left ventricle using the at least one additional electrode and determining if the cardiac activation at the other site occurs within an expected conduction delay window from the cardiac activation at the first site.

10. A method for using at least two electrodes implanted in or proximate to a heart chamber, comprising:

using a first electrode operationally positioned proximate to a first site of the heart chamber to pace the first site, wherein using the first electrode to pace the first site includes delivering a programmed pacing therapy to pace the heart chamber at the first site using the first electrode;

sensing at the first site; and

using a second electrode operationally positioned proximate to a second site of the heart chamber to provide pacing redundancy for the heart chamber based on the sensing at the first site,

wherein the programmed pacing therapy to pace the heart chamber using the first electrode does not pace the second site using the second electrode if the heart chamber is paced at the first site using the first electrode, using the second electrode to provide pacing redundancy for the heart chamber includes responding to a failure or an algorithm that inhibits a pace to the first site, and responding includes pacing the heart chamber by delivering a. pace to the second site using the second electrode.

11. The method of claim 10, wherein the first electrode is operationally positioned to pace a first left ventricular site and the second electrode is operationally positioned to pace a second left ventricular site.

12. A method for using at least two electrodes implanted in or proximate to a heart chamber, comprising:

using a first electrode operationally positioned proximate to a first site of the heart chamber to pace the first site or to sense a cardiac activation at the first site, wherein using the first electrode to pace the first site includes delivering a programmed pacing therapy to pace the heart chamber at the first site using the first electrode;

verifying electrical propagation in heart tissue attributed to the pace or the sensed cardiac activation using multiple site cross-checking; and

using a second electrode operationally positioned proximate to a second site of the heart chamber to provide pacing redundancy for the heart chamber based on the multiple-site cross checking,

wherein the programmed pacing therapy to pace heart chamber using the first electrode does not pace the second site using the second electrode if the heart chamber is paced at the first site using the first electrode, using the second electrode to provide pacing redundancy for the heart chamber includes responding to a failure or an algorithm that inhibits a pace to the first site, and responding includes pacing the heart chamber by delivering a pace to the second site using the second electrode.

13. The method of claim 12, wherein the first electrode is operationally positioned to pace a first left ventricular site and the second electrode is operationally positioned to pace a second left ventricular site.

14. The method of claim 13, wherein verifying electrical propagation includes verifying electrical propagation in the left ventricle using multiple site cross-checking.

15. A method for using at least two electrodes implanted in or proximate to a heart chamber, wherein the at least two electrodes include a first electrode and a second electrode, the method comprising:

pacing a first site of the heart chamber using the first electrode;

verifying that the first site of the heart chamber is paced, wherein verifying includes sensing cardiac activation at a second site of the heart chamber using the second electrode, wherein verifying includes determining if the cardiac activation at the second site occurs within an expected conduction delay window; and

pacing the second site of the heart chamber if the cardiac activation is not sensed at the second site within the expected conduction delay window.

16. The method of claim 15, wherein the first and second electrodes are on the same lead.

17. The method of claim 15, including determining that the first site was not paced because of a failure condition if the cardiac activation at the second site does not occur within an expected conduction delay window.

18. An implantable medical device, comprising:

at least a first electrode and a second electrode;

means for using the first electrode operationally positioned proximate to a first site of a heart chamber to pace the first site using a programmed pacing therapy to pace the first site or to sense a cardiac activation at the first site, wherein the second electrode is not used with the first electrode to pace the first site or to sense the cardiac activation at the first site; and

means for using the second electrode operationally positioned proximate to a second site of the heart chamber to provide pacing redundancy for the heart chamber or to provide sensing redundancy for the heart chamber,

wherein the programmed pacing therapy to pace the first site using the first electrode does not pace the second site using the second electrode if the heart chamber is paced at the first site using the first electrode, the means for using the second electrode to provide pacing redundancy for the heart chamber includes means for responding to a failure or an algorithm that inhibits a pace to the first site, and the means for responding includes means for pacing the heart chamber by delivering a pace to the second site instead of the first site.

19. The device of claim 18, wherein:

the means for using the first electrode includes means for pacing the first site of the heart chamber using the first electrode; and

the means for using the second electrode includes means for sensing cardiac activation at the second site of the heart chamber using the second electrode and means for determining if cardiac activation at the second site occurs within an expected conduction delay window from a time when the first site is paced.

20. The device of claim 18, wherein:

the means for using the first electrode includes means sensing the cardiac activation at the first site of the heart chamber using the first electrode; and

the means for using the second electrode includes means for sensing cardiac activation at the second site of the heart chamber using the second electrode and means for determining if the cardiac activation at the second site occurs within an expected conduction delay window from the cardiac activation at the first site.

21. An implantable medical device, comprising:

at least one implantable lead configured to position at least a first electrode and a second electrode in or proximate to a heart chamber;

a pace output circuit configured to pace a first site of the heart chamber using the first electrode and to pace the second site of the heart chamber using the second electrode;

a sensing circuit configured to sense cardiac activation at a second site of the heart chamber using the second electrode;

a control circuit connected to the pace output circuit and to the sensing circuit, wherein the control circuit is configured to verify that the first site of the heart chamber is paced to induce a conducted event by sensing the conducted event at the second site, wherein the controller is configured to provide pacing redundancy by pacing the second site of the heart chamber using the second electrode if the conducted event is not sensed at the second site within an expected conduction delay window.

22. The device of claim 21, wherein the at least one implantable lead includes one lead with both the first and second electrodes.

23. The device of claim 21, wherein the control circuit is configured to verify that the first site of the heart chamber is paced if the conducted event is sensed within an expected conduction delay window.